Table 2 Intraoperative and postoperative variables
Group A | Group B | Group C | Group D | P | |
|---|---|---|---|---|---|
Estimated bleeding (ml) (mean ± SD) (min–max) | 182 ± 53.89 (100–285) | 192 ± 122.77 (100–500) | 192.5 ± 111.54 (50–500) | 134 ± 82.99 (20–450) | 0.180 |
Drainage time (days) (mean ± SD) (min–max) | 2.25 ± 0.44 (2–3) | 2.4 ± 0.5 (2–3) | 2.35 ± 1.31 (1–7) | 1.65 ± 0.93 (1–5) | 0.029** |
Urinary catheter time (days) (mean ± SD) (min–max) | 9.25 ± 1.07 (7–11) | 9.9 ± 1.74 (7–14) | 9.3 ± 2.18 (7–17) | 8.55 ± 1.61 (7–14) | 0.105 |
Hospitalization time (days) (mean ± SD) (min–max) | 5.2 ± 1.28 (4–9) | 5.15 ± 1.23 (3–9) | 4.7 ± 2.9 (3–15) | 4.65 ± 1.76 (2–10) | 0.711 |
Surgical time (Mean ± SD) (min–max) | 177.8 ± 47.13 (112–250) | 161.55 ± 46.9 (103–253) | 160.65 ± 43.93 (105–270) | 126.8 ± 5.48 (120–136) | 0.001* |
Nerve sparing (%) | |||||
None | 14 (70%) | 10 (50%) | 14 (70%) | 11 (55%) | 0.429 |
Unilateral | 1 (5%) | 1 (5%) | 3 (15%) | 2 (10%) | |
Bilateral | 5 (25%) | 9 (45%) | 3 (15%) | 7 (35%) | |
Clinic stage: n (%) | |||||
T2 | 10 (50%) | 7 (35%) | 11 (55%) | 12 (60%) | 0.423 |
T3 | 10 (50%) | 13 (65%) | 9 (45%) | 8 (40%) | |
Gleason score (%) | |||||
≤ 6 (%) | 10 ( 50%) | 14 (70%) | 16 (80%) | 13 (65%) | 0.523 |
7 (%) | 7 (35%) | 3 (15%) | 3 (15%) | 4 (20%) | |
> 7 (%) | 3 (15%) | 3 (15%) | 1 (5%) | 3 (15%) | |